News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Bayer AG: No Decision Yet On Job Cuts At Pharmaceutical Unit, Company Rejects Rumor of Concrete Plans to Slash 700 Jobs in Germany
February 7, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT -(Dow Jones)- German pharmaceuticals and chemicals conglomerate Bayer AG (BAYN.XE) Sunday rejected a magazine report according to which there are concrete plans to slash up to 700 jobs in Germany at locations of its pharmaceutical unit.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
Europe
MORE ON THIS TOPIC
Career Advice
The Top 12 Companies Hiring in Biopharma Now
April 2, 2026
·
1 min read
·
Angela Gabriel
Job Trends
Innovation Pressure Cooker: Tackling Drug Discovery’s Biggest Challenges
April 2, 2026
·
5 min read
·
Angela Gabriel
Layoffs
Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment
April 1, 2026
·
2 min read
·
Nick Paul Taylor
Career Advice
3 Career Moves R&D Professionals Must Make in a Skills-Based, AI-Driven Economy
April 1, 2026
·
5 min read
·
Kenneth Munie